Many compounds giving a positive result in animal carcinogenicity studies through mechanisms involving secondary carcinogenesis pose little or no risk to humans. This article provides an overview of current understanding, with particular reference to renal tumors in male rats with α2μ-globulin nephropathy, urinary bladder neoplasia in rodents, mesovarian leiomyomas induced in rats by β2-receptor stimulants, carcinoid tumors in the rodent stomach induced by prolonged suppression of acid secretion, thyroid follicular cell tumors in rodents, canine mammary neoplasia due to administration of progestagens, rodent mammary neoplasia induced by estrogens, uterine endometrial carcinomas of rats induced by dopamine agonists, Leydig cell tumors in the testis of rats, and ovarian tubulostromal adenomas in mice. A positive result on a rodent carcinogenicity study should not automatically preclude further development of a compound; future progress in this field should increase the accuracy of the rodent carcinogenicity study as a tool in human safety assessment.
1. Alden CL (1986). A review of unique male rat hydrocarbon nephropathy.Toxicol. Pathol.14: 109–111.
2.
2. Alden CL and Frith CH (1991). Urinary system. In: Handbook of Toxicologic Pathology, WM Haschek and CG Rousseaux (eds). Academic Press, San Diego, pp. 315–387.
3.
3. Alison RH and Morgan KT (1987). Ovarian neoplasms in F344 rats and B6C3F1 mice.Environ. Health Perspect.73: 91–106.
4.
4. Alison RH, Morgan KT, Haseman JK, and Boorman GA (1987). Morphology and classification of ovarian neoplasms in F344 rats and (C57BL/6 × C3H)F1 mice.JNCI78: 1229–1243.
5.
5. Baetke KP, Hard GC, Rodgers IS, et al (1991). Alpha2μ-globulin: Association with chemically induced renal toxicity and neoplasia in the male rat. Risk Assessment Forum.U.S. Environmental Protection Agency 625/3-91/019F, Washington, D.C.
6.
6. Beamer W and Capen CC (1990). Pathobiology of sterility-associated ovarian tumors in mice. In: Toxicology Forum. Proceedings of the 1990 Annual Summer Meeting, Aspen, Colorado, July 16–20, pp. 308–334.
7.
7. Betton GR, Dormer C, Wells T, Pert P, Price CA, and Buckley P (1988). Gastric ECL cell hyperplasia and carcinoids in rodents following chronic administration of H2 antagonists SK & F 93479 and oxmetidine and omeprazole.Toxicol. Pathol.16: 288–298.
8.
8. Burek JD, Patrick DH, and Gerson RJ (1988). Weight-of-biological evidence approach for assessing carcinogenicity. In: Carcinogenicity, HC Grice and JL Cimina (eds). Springer-Verlag, New York, pp. 83–95.
9.
9. Capen CC, DeLellis RA, and Yarrington JT (1991). Endocrine system. In: Handbook of Toxicologic Pathology, WM Haschek and CG Rousseaux (eds). Academic Press, San Diego, pp. 675–760.
10.
10. Capen CC and Martin SL (1989). The effects of xenobiotics on the structure and function of thyroid follicular and C-cells.Toxicol. Pathol.17: 266–293.
11.
11. Charbonneau M, Strasser J, Borghoff SJ, and Swenberg JA (1988). In vitro hydrolysis of [14C]-alpha2μ-globulin (alpha2u) isolated from male rat kidney. Toxicologist8: 135 (abstract).
12.
12. El Etreby MF and Gräf KJ (1979). Effect of contraceptive steroids on mammary gland of beagle dog and its relevance to human carcinogenicity.Pharmacol. Ther.5: 369–402.
13.
13. Faccini JM, Butler WR, Friedmann JC, Hess R, Reznik GK, Ito N, Hayashi Y, and Williams GM (1992). IFSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassay.Exp. Toxicol. Pathol.44: 443–456.
14.
14. Gopinath C and Gibson WA (1987). Mesovarian leiomyomas in the rat.Environ. Health Perspect.73: 107–113.
15.
15. Griffith RW (1988). Carcinogenic potential of marketed drugs.J. Clin. Res. Drug Dev.2: 141–144.
16.
16. Havu N (1986). Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion35(suppl. 1): 42–55.
17.
17. Jack D, Poynter D, and Spurling NW (1983). Beta-adrenoceptor stimulants and mesovarian leiomyomas in the rat.Toxicology27: 315–320.
18.
18. Lehman-McKeeman LD, Rivera-Torres MI, and Caudill D (1990). Lysosomal degradation of alpha2μ-globulin and alpha2μ-globulin-xenobiotic conjugates.Toxicol. Appl. Pharmacol.103: 539–548.
19.
19. Manson JM and Mattson BA (1992). Susceptibility of the ovary to toxic substances. In: Pathobiology of the Aging Rat, Vol. 1, U Mohr, DL Dungworth, and CC Capen (eds). ILSI Press, Washington, D.C., pp. 365–376.
20.
20. McClain RM (1989). The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia.Toxicol. Pathol.17: 294–306.
21.
21. Mobley TL, Coyle JK, Al-Hussaini M, and McDonald DF (1966). The role of chronic mechanical irritation in experimental urothelial tumorigenesis.Invest. Urol.3: 325–333.
22.
22. Neuhaus OW, Floey W, Biswas N, and Hollerman CE (1981). Urinary excretion of alpha2μ-globulin and albumin by adult male rats following treatment with nephrotoxic agents.Nephron28: 133–140.
23.
23. Neumann F (1991). Early indicators for carcinogenesis in hormone-sensitive organs.Mutation Res.248: 341–356.
24.
24. Oyasu R, Iwasaki T, and Ozono S (1984). Diffuse papillomatosis of rat urinary bladder occurring in association with vesical calculi.J. Urol.132: 1012–1015.
25.
25. Paynter OE, Burin GJ, Jaeger RB, and Gregorio CA (1988). Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process.Reg. Toxicol.8: 102–119.
26.
26. Prentice DE and Meikle W (1994). A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat: Important differences from man. Fund. Appl. Toxicol. (in press).
27.
27. Shirai T, Ikawa E, Fukushima S, Masui T, and Ito N (1986). Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats.Cancer Res.46: 2062–2067.
28.
28. Soll AH (1990). Pathogenesis of peptic ulcer and implications for therapy.N. Engl. J. Med.322: 909–916.
29.
29. Stitzel KA, McConnel RF, and Dierckman TA (1989). Effects of nitrofurantoin on the primary and secondary reproductive organs of female B6C3F1 mice.Toxicol. Pathol.17: 774–781.
30.
30. Swenberg JA, Short B, Borghoff S, Strasser J, and Charbonneau M (1989). The comparative pathobiology of alpha2μ-globulin nephropathy.Toxicol. Appl. Pharmacol.97: 35–46.
31.
31. Thomas DB (1987). The breast. Paper read at the WHO symposium on improving safety requirements for contraceptive steroids. Geneva, February 2–5, 1987.
32.
32. Toyoshima K and Leighton J (1975). Bladder calculi and urothelial hyperplasia with papillomatosis in the rat following insertion of chalk powder in the bladder cavity with subsequent trauma of the bladder wall.Cancer Res.35: 3786–3791.
33.
33. US Department of Health and Human Services (1989). Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice. National Toxicology Program, Technical Report Series No. 341. Public Health Service, National Institutes of Health, Washington, D.C. NIH Publication No. 88-2597.
34.
34. Zbinden G (1987). Assessment of hyperplastic and neoplastic lesions of the thyroid gland.Trends Pharmacol.8: 511–514.
35.
35. Zbinden G (1987). Predictive value of animal studies in toxicology. CMR Annual Lecture.Centre for Medicines Research, Carshalton, UK.
